(Q39218802)

10 September 2017

MicroRNA-21 regulates the sensitivity of diffuse large B-cell lymphoma cells to the CHOP chemotherapy regimen (English)

1 reference

diffuse large B-cell lymphoma

10 September 2017

1 reference

1 reference

1 reference

1 reference

Haitao Bai

1

1 reference

10 September 2017

Ju Wei

2

1 reference

10 September 2017

Chong Deng

3

1 reference

10 September 2017

Xiaoyu Yang

4

1 reference

10 September 2017

Chun Wang

5

1 reference

10 September 2017

Rang Xu

6

1 reference

10 September 2017

30 December 2012

1 reference

International Journal of Hematology

10 September 2017

1 reference

10 September 2017

97

1 reference

10 September 2017

2

1 reference

10 September 2017

223-231

1 reference

https://scigraph.springernature.com/pub.10.1007/s12185-012-1256-x

10 September 2017

0 references

cites work

Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1256-X

Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1256-X

Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1256-X

Drug resistance in diffuse large B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1256-X

MicroRNAs: small RNAs with a big role in gene regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1256-X

miRNAs, cancer, and stem cell division

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1256-X

MicroRNAs modulate the chemosensitivity of tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1256-X

miR-21: a small multi-faceted RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1256-X

14-3-3zeta mediates resistance of diffuse large B cell lymphoma to an anthracycline-based chemotherapeutic regimen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1256-X

Inhibition of geranylgeranylation mediates sensitivity to CHOP-induced cell death of DLBCL cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1256-X

Real-time quantification of microRNAs by stem-loop RT-PCR

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1256-X

Involvement of miR-21 in resistance to daunorubicin by regulating PTEN expression in the leukaemia K562 cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1256-X

MicroRNA expression distinguishes between germinal center B cell-like and activated B cell-like subtypes of diffuse large B cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1256-X

Suppression of PTEN function increases breast cancer chemotherapeutic drug resistance while conferring sensitivity to mTOR inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1256-X

PTEN-mediated resistance to epidermal growth factor receptor kinase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1256-X

MicroRNA-21 in pancreatic cancer: correlation with clinical outcome and pharmacologic aspects underlying its role in the modulation of gemcitabine activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1256-X

MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1256-X

MicroRNA gene expression deregulation in human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1256-X

A microRNA expression signature of human solid tumors defines cancer gene targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1256-X

OncomiR addiction in an in vivo model of microRNA-21-induced pre-B-cell lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1256-X

Hyaluronan-CD44 interaction with protein kinase C(epsilon) promotes oncogenic signaling by the stem cell marker Nanog and the Production of microRNA-21, leading to down-regulation of the tumor suppressor protein PDCD4, anti-apoptosis, and chemothera

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1256-X

MiR-21 protected human glioblastoma U87MG cells from chemotherapeutic drug temozolomide induced apoptosis by decreasing Bax/Bcl-2 ratio and caspase-3 activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1256-X

MicroRNA-21 targets LRRFIP1 and contributes to VM-26 resistance in glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1256-X

MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1256-X

MicroRNA-21 directly targets MARCKS and promotes apoptosis resistance and invasion in prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1256-X

MicroRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1256-X

Involvement of human micro-RNA in growth and response to chemotherapy in human cholangiocarcinoma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1256-X

MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1256-X

Protein expression and cellular localization in two prognostic subgroups of diffuse large B-cell lymphoma: higher expression of ZAP70 and PKC-beta II in the non-germinal center group and poor survival in patients deficient in nuclear PTEN.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1256-X

Determinants of sensitivity and resistance to rapamycin-chemotherapy drug combinations in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1256-X

Target of rapamycin signaling in leukemia and lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1256-X

Role of phosphatidylinositol 3'-kinase/AKT pathway in diffuse large B-cell lymphoma survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1256-X

Activation of mammalian target of rapamycin signaling pathway contributes to tumor cell survival in anaplastic lymphoma kinase-positive anaplastic large cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1256-X

Recent prognostic factors in diffuse large B-cell lymphoma indicate NF-kappaB pathway as a target for new therapeutic strategies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1256-X

DNA damage induces NF-κB-dependent microRNA-21 up-regulation and promotes breast cancer cell invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1256-X

Akt, 14-3-3ζ, and vimentin mediate a drug-resistant invasive phenotype in diffuse large B-cell lymphoma

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23275230

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Genistein sensitizes diffuse large cell lymphoma to CHOP (cyclophosphamide, doxorubicin, vincristine, prednisone) chemotherapy.

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23275230

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Rituximab plus CHOP (R-CHOP) overcomes PRDM1-associated resistance to chemotherapy in patients with diffuse large B-cell lymphoma

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23275230

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S12185-012-1256-X

1 reference

10 September 2017

1 reference